Tue, February 18, 2020

Andrew Berens Maintained (BPMC) at Buy with Decreased Target to $103 on, Feb 18th, 2020

Andrew Berens of Morgan Stanley, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $108 to $103 on, Feb 18th, 2020.

Andrew has made no other calls on BPMC in the last 4 months.



There are 3 other peers that have a rating on BPMC. Out of the 3 peers that are also analyzing BPMC, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • George Farmer of "BMO Capital" Initiated at Hold and Held Target at $74 on, Tuesday, January 28th, 2020
  • Konstantinos Aprilakis of "Deutsche Bank" Maintained at Hold with Decreased Target to $70 on, Tuesday, December 10th, 2019


This is the rating of the analyst that currently disagrees with Andrew


  • Dane Leone of "Raymond James" Upgraded from Buy to Strong Buy on, Wednesday, November 6th, 2019